Clinical trial
Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans
NCT02710370
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedIntestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans
Design: OBSERVATIONAL · Status: ACTIVE NOT RECRUITING · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Obesityverified · MONDO: obesity disorder
Endocrine System Diseasesunresolved
Glucose Metabolism Disordersunresolved
Metabolic Diseasesunresolved
Interventions
Sponsors & collaborators
University of Pittsburghlead sponsor
Harvard Universitycollaborator
National Institutes of Health (NIH)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02710370 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.